Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Stryker Corporation

NYSE

Market Cap.

127.82B

Avg. Volume

1.26M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Stryker Corporation!

Still processing it, give me a bit more time...

Stryker Corporation News

Stryker Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
stryker.com

About Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Stryker Corporation Earnings & Revenue

Stryker Corporation Financials

Table Compare

Compare SYK metrics with:

   

Earnings & Growth

SYK

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

SYK

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

SYK

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

SYK

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Stryker Corporation Income

Stryker Corporation Balance Sheet

Stryker Corporation Cash Flow

Stryker Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Stryker Corporation Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

3.1500

Payment DateDividendFrequency
2024-07-310.8Quarterly
2024-04-300.8Quarterly
2024-01-310.8Quarterly
2023-10-310.75Quarterly
2023-07-310.75Quarterly

Historical Market Cap

Shares Outstanding

Stryker Corporation Executives

NameRole
Mr. Kevin A. LoboChairman, Chief Executive Officer & President
Mr. Glenn S. BoehnleinVice President & Chief Financial Officer
Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology
Mr. Spencer S. StilesGroup President of Orthopaedics & Spine
Mr. Viju S. MenonGroup President of Global Quality & Operations
NameRoleGenderDate of BirthPay
Mr. Kevin A. LoboChairman, Chief Executive Officer & PresidentMale19655.7M
Mr. Glenn S. BoehnleinVice President & Chief Financial OfficerMale19622.27M
Mr. J. Andrew PierceGroup President of MedSurg & NeurotechnologyMale19742.03M
Mr. Spencer S. StilesGroup President of Orthopaedics & SpineMale19772.02M
Mr. Viju S. MenonGroup President of Global Quality & OperationsMale19681.68M

Stryker Corporation Insider Trades

Date22 May
NameFletcher Robert S
RoleVP, Chief Legal Officer
TransactionDisposed
TypeS-Sale
Shares2007
Date15 May
NameBoehnlein Glenn S
RoleVP, Chief Financial Officer
TransactionDisposed
TypeS-Sale
Shares10000
Date9 May
NameSuri Rajeev
RoleDirector
TransactionAcquired
TypeA-Award
Shares653
Date9 May
NameSTRYKER RONDA E
RoleDirector, 10 percent owner
TransactionAcquired
TypeA-Award
Shares653
Date9 May
NameSkeete Tatum Lisa M
RoleDirector
TransactionAcquired
TypeA-Award
Shares653
DateNameRoleTransactionTypeShares
22 MayFletcher Robert SVP, Chief Legal OfficerDisposedS-Sale2007
15 MayBoehnlein Glenn SVP, Chief Financial OfficerDisposedS-Sale10000
9 MaySuri RajeevDirectorAcquiredA-Award653
9 MaySTRYKER RONDA EDirector, 10 percent ownerAcquiredA-Award653
9 MaySkeete Tatum Lisa MDirectorAcquiredA-Award653

Discover More

Streamlined Academy

Stryker Corporation

NYSE

Market Cap.

127.82B

Avg. Volume

1.26M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Stryker Corporation News

Stryker Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Stryker Corporation Earnings & Revenue

Stryker Corporation Income

Stryker Corporation Balance Sheet

Stryker Corporation Cash Flow

Stryker Corporation Financials Over Time

Stryker Corporation Executives

NameRole
Mr. Kevin A. LoboChairman, Chief Executive Officer & President
Mr. Glenn S. BoehnleinVice President & Chief Financial Officer
Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology
Mr. Spencer S. StilesGroup President of Orthopaedics & Spine
Mr. Viju S. MenonGroup President of Global Quality & Operations
NameRoleGenderDate of BirthPay
Mr. Kevin A. LoboChairman, Chief Executive Officer & PresidentMale19655.7M
Mr. Glenn S. BoehnleinVice President & Chief Financial OfficerMale19622.27M
Mr. J. Andrew PierceGroup President of MedSurg & NeurotechnologyMale19742.03M
Mr. Spencer S. StilesGroup President of Orthopaedics & SpineMale19772.02M
Mr. Viju S. MenonGroup President of Global Quality & OperationsMale19681.68M

Stryker Corporation Insider Trades

Date22 May
NameFletcher Robert S
RoleVP, Chief Legal Officer
TransactionDisposed
TypeS-Sale
Shares2007
Date15 May
NameBoehnlein Glenn S
RoleVP, Chief Financial Officer
TransactionDisposed
TypeS-Sale
Shares10000
Date9 May
NameSuri Rajeev
RoleDirector
TransactionAcquired
TypeA-Award
Shares653
Date9 May
NameSTRYKER RONDA E
RoleDirector, 10 percent owner
TransactionAcquired
TypeA-Award
Shares653
Date9 May
NameSkeete Tatum Lisa M
RoleDirector
TransactionAcquired
TypeA-Award
Shares653
DateNameRoleTransactionTypeShares
22 MayFletcher Robert SVP, Chief Legal OfficerDisposedS-Sale2007
15 MayBoehnlein Glenn SVP, Chief Financial OfficerDisposedS-Sale10000
9 MaySuri RajeevDirectorAcquiredA-Award653
9 MaySTRYKER RONDA EDirector, 10 percent ownerAcquiredA-Award653
9 MaySkeete Tatum Lisa MDirectorAcquiredA-Award653

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
stryker.com

About Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Stryker Corporation!

Still processing it, give me a bit more time...

Stryker Corporation Financials

Table Compare

Compare SYK metrics with:

   

Earnings & Growth

SYK

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

SYK

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

SYK

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

SYK

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Stryker Corporation Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

3.1500

Payment DateDividendFrequency
2024-07-310.8Quarterly
2024-04-300.8Quarterly
2024-01-310.8Quarterly
2023-10-310.75Quarterly
2023-07-310.75Quarterly

Stryker Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More